Research Article
Methylation Status of Alu and LINE-1 Interspersed Repetitive Sequences in Behcet’s Disease Patients
Table 2
LINE-1 methylation frequency of BD patients and healthy controls. The results represented as the average ± standard deviation.
| | % C | % CC | % CC | % CC | % CC | % CC + CC |
| PBMC control () | 81.76 ± 2.04 | 81.76 ± 2.04 | 9.62 ± 3.39 | 16.42 ± 1.08 | 5.22 ± 1.07 | 26.05 ± 3.87 | PBMC active () | 81.61 ± 1.63 | 68.93 ± 2.59 | 8.29 ± 1.92 | 17.07 ± 1.39 | 5.71 ± 0.80 | 25.37 ± 2.03 | PBMC inactive () | 81.15 ± 1.18 | 68.21 ± 1.57 | 9.80 ± 1.97 | 16.07 ± 1.28 | 5.92 ± 1.59 | 25.87 ± 2.10 | PBMC all patients () | 81.34 ± 1.37 | 68.51 ± 2.04 | 9.18 ± 2.06 | 16.48 ± 1.40 | 5.83 ± 1.31 | 25.66 ± 2.05 |
| Neutrophil control () | 81.06 ± 1.94 | 67.73 ± 2.92 | 11.01 ± 2.03 | 15.64 ± 0.55 | 5.61 ± 1.20 | 26.65 ± 2.23 | Neutrophil active () | 82.07 ± 0.96 | 69.12 ± 1.39 | 10.06 ± 1.20 | 15.86 ± 1.32 | 4.97 ± 0.61 | 25.92 ± 0.98 | Neutrophil inactive () | 81.35 ± 1.25 | 67.82 ± 2.04 | 11.06 ± 2.54 | 16.01 ± 1.73 | 5.11 ± 0.89 | 27.07 ± 1.91 | Neutrophil all patients () | 81.65 ± 1.18 | 68.36 ± 1.89 | 10.64 ± 2.12 | 15.95 ± 1.55 | 5.05 ± 0.78 | 26.59 ± 1.67 |
|
|